��

��. ��:

21-Jul-2000

�� , 16(6), ��-�� 1999, 602-604

��

H ��
��

�. ��, �. ��, �. ��, �. ��
�� , ��

�� : ��, �� , HCV-��

�� ¹ �� John Cade �� , �� , �� , �� .² �� , �� , �� , �� .^3,4 ��, �� , �� ^4,5 �� ,^4,6 �� , �� , �� . �� , �� , �� , �� HCV-��.

�� 

�� 26 �� . �� , � ��, � �� , � �� , � �� , �� , �� (32 �� Beck �� Rafaelsen � �� 15).

�� 21 ��, �� . �� , �� . �� , �� , �� . �� HCV-��. � �� . � �� , �� , �� , �� . � �� . �� , �� 19 ��. �� . �� . �� .

�� (SGOT 98 U/L, SGPT 55 U/L, �� <45 U/L), �� GT �� (19 U/L, �� <31 U/L).

�� 65 mg �� 600 mg �� . �� (BRMAS: 22) �� (�� 1200 mg/��). �� , �� , �� .

� �� , �� (�� ).

� �� (BRMAS: 10), �� . ��, � �� , �� , �� . �� , �� , �� .

��

�� , �� .⁷ �� , �� (��) �� , �� .⁸ �� , �� .^9,10 �� , � �� , �� C.

� �� , �� P450, �� 98% �� , �� -��. � �� 5�15% �� . ��, ��, �� 450, �� , �� , ��, �� . �� : (�) �� 450 �� (�) �� -��. �� 44% �� , �� .³

�� , �� , �� , �� 95% �� .¹¹ � �� , �� , �� , �� , �� , �� .¹²

�� , �� .¹³ �� .¹⁴ �� , ��, �� , �� , �� : �� , �� . ��, �� . �� , �� , �� , ��, �� .

��

CADE JFJ. Lithium salts in the treatment of psychotic excitement. Med J Aust 1949, 36:349�352
FRIEDRICH MJ. Lithium: proving its mettle for 50 years. JAMA 1999, 281:2271�2273
KECK PE, McELROY SL. Antiepileptic drugs. In: Schatzberg AF, Nemeroff CB (eds) Textbook of Psychopharmacology. 2nd ed. Ameri can Psychiatric Press, 1998:431�454
POST RM, DENIKOFF KD, FRYE MA ET AL. A history of the use of anticonvulsants as mood stabilizers in the last two decades of the 20th century. Neuropsychobiology 1998, 38:152�156
SPORN J, SACHS G. The anticonvulsant lamotrigine in treatment-resistant manic-depressive illness. J Clin Psychopharmacol 1997, 17:185�189
McELROY SL, SOUTULLO CA, KERK PE Jr, KMETZ GF. A Pilot trial of adjunctive gabapentin in the treatment of bipolar disorder. Ann Clin Psychiatry 1997, 9:99�103
SWANN AC. Selection of a first-line mood stabilizing agent. Curr Opin Psychiatry 1998, 11:71�75
KUSUMAKAR V, YATHMA LN, HASLAM DRS ET AL. Treatment of mania. Mixed state and rapid cycling. Can J Psychiatry 1997, 42(Suppl 2): 79S�86S
CALABRESE JR, BOWDEN CL, McELROY SL ET AL. Spectrum of activity of lamotrigine in treatment of refractory bipolar disorder. Am J Psychiatry 1999, 156:1019�1023
KNOLL J, STEGMAN K, SUPPES T. Clinical experience using gabapentin adjunctively in patients with a history of mania or hypomania. J Affect Disord 1998, 49:229�223
LENOX RH, MANJI H. Lithium. In: Schatzberg AF, Nemeroff CB (eds) Textbook of Psychopharmacology. 2nd ed. American Psychiatric Press, 1998:379�429
ELWES RD, BINNIE CD. Clinical pharmacokinetics of newer antiepi leptic drugs. Lamotrigine, vigabatrin, gabapentin and oxcarba zepine. Clin Pharmacokinet 1996, 30:403�415
HATZIMANOLIS J, LYKOURAS K, OULIS P, CHRISTODOULOU GN. Gaba pentin as monotherapy in the treatment of acute mania. Eur Neuropsychopharmacol 1999, 9:257�258
BENNETT J, GOLDMAN WT, SUPPES T. Gabapentine for treatment of bipolar and schizoaffective disorders. J Clin Psychopharmacol 1997, 17:141�142

� 2000, ��